BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim N, Myoung Noh J, Lee W, Park B, Park H, Young Park J, Pyo H. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy. Radiother Oncol 2021;156:166-73. [PMID: 33359267 DOI: 10.1016/j.radonc.2020.12.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Deutsch E, Cengel KA, Galluzzi L, Levy A. Could Protons Promote Tumor Control by Avoiding Lymphopenia? J Thorac Oncol 2021;16:e39-41. [PMID: 34034888 DOI: 10.1016/j.jtho.2021.01.1614] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Durante M, Debus J, Loeffler JS. Physics and biomedical challenges of cancer therapy with accelerated heavy ions. Nat Rev Phys 2021;3:777-90. [PMID: 34870097 DOI: 10.1038/s42254-021-00368-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chow R, Simone CB. In Regard to Damen et al. International Journal of Radiation Oncology*Biology*Physics 2022;113:235-6. [DOI: 10.1016/j.ijrobp.2022.01.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Helm A, Fournier C, Durante M. Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications. Expert Rev Mol Med 2022;24:e8. [PMID: 35101155 DOI: 10.1017/erm.2022.2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Boer CG, Fjellanger K, Sandvik IM, Ugland M, Engeseth GM, Hysing LB. Substantial Sparing of Organs at Risk with Modern Proton Therapy in Lung Cancer, but Altered Breathing Patterns Can Jeopardize Target Coverage. Cancers (Basel) 2022;14:1365. [PMID: 35326516 DOI: 10.3390/cancers14061365] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Qiu B, Men Y, Wang J, Hui Z. Dosimetry, Efficacy, Safety, and Cost-Effectiveness of Proton Therapy for Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:4545. [PMID: 34572772 DOI: 10.3390/cancers13184545] [Reference Citation Analysis]
7 Damen PJ, Kroese TE, Peters M, Lin SH, Verhoeff JJ, van Rossum PS. In Reply to Chow and Simone. International Journal of Radiation Oncology*Biology*Physics 2022;113:236-7. [DOI: 10.1016/j.ijrobp.2022.01.040] [Reference Citation Analysis]
8 Yoo GS, Yu JI, Park HC. Current role of proton beam therapy in patients with hepatocellular carcinoma. Int J Gastrointest Interv 2021;10:175-82. [DOI: 10.18528/ijgii210043] [Reference Citation Analysis]
9 Pompos A, Foote RL, Koong AC, Le QT, Mohan R, Paganetti H, Choy H. National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States. Front Oncol 2022;12:880712. [DOI: 10.3389/fonc.2022.880712] [Reference Citation Analysis]
10 Algranati C, Strigari L. Imaging Strategies in Proton Therapy for Thoracic Tumors: A Mini Review. Front Oncol 2022;12:833364. [DOI: 10.3389/fonc.2022.833364] [Reference Citation Analysis]
11 Monti S, Xu T, Liao Z, Mohan R, Cella L, Palma G. On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients. Radiother Oncol 2021;167:219-25. [PMID: 34979216 DOI: 10.1016/j.radonc.2021.12.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]